Chicken beta-actin hybrid intron (CBh) promoter
Compact hybrid promoter combining the CMV immediate-early enhancer with the chicken β-actin promoter, engineered by replacing the CBA promoter's SV40 intron with a chimeric chicken β-actin/MVM intron. Drives strong, ubiquitous constitutive expression, including in spinal and brainstem motor neurons where the parental CBA promoter performs poorly.
Origin: Engineered from CBA, SV40 intron replaced with a chimeric intron
Characteristics
~800 bp promoter derived from the CBA promoter by substituting a hybrid intron (5' donor splice site from the chicken β-actin 5' UTR, 3' acceptor from the minute virus of mice) for the SV40 intron. In AAV9-transduced rat CNS and PNS tissue, produces GFP expression comparable to the CMV promoter within 48-72 hours, including 30-40 GFP-positive motor neuron-like cells per 40-µm section versus 2-4 for CBA. Unlike CMV, expression remains unchanged 10 weeks post-injection, while CMV-driven expression declines significantly over the same period (Gray et al. 2011).
Applications: Used in self-complementary and single-stranded AAV vectors for CNS and PNS gene delivery in rodents, including targeting of spinal and brainstem motor neurons where CMV and CBA underperform; suited to long-term (>10 week) reporter and therapeutic transgene expression studies (Gray et al. 2011).
Limitations: Long-term performance beyond the 10-week endpoint tested by Gray et al. (2011) is not established. Extensive glial co-expression in AAV9-transduced CNS tissue can obscure quantification of motor-neuron-specific expression. At ~800 bp, still consumes meaningful capacity in size-constrained AAV constructs.